A novel biomarker for the detection of esophageal adenocarcinoma

Slides:

Advertisements

Similar presentations

Diagnosis of Esophageal Adenocarcinoma by Serum Proteomic Pattern

Advertisements

Lost in translation The Journal of Thoracic and Cardiovascular Surgery

Manuel J. Antunes, MD, PhD, DSc

Stephen R. Broderick, MD, MPHS

A wolf in sheep's clothing

The eighth edition TNM stage classification for lung cancer: What does it mean on main street? Frank C. Detterbeck, MD The Journal of Thoracic and Cardiovascular.

Prediction of severe acute kidney injury after pediatric cardiac surgery with the use of novel biomarkers: A new trend in clinical research and risk stratification

Adenocarcinoma arising from cervical esophageal gastric inlet patch

Lung cancer screening: No more excuses

Supercharged through a tunnel, is it an action movie

The days of future past Neel K. Ranganath, MD, Aubrey C. Galloway, MD

Intrinsic cardiac stem cells are essential for regeneration

Centers for Disease Control “increased-risk” organ donor: Not so risky? Francis D. Pagani, MD, PhD The Journal of Thoracic and Cardiovascular Surgery

Abracadabra I, II…HeartMate 3?

Form ever follows function

Victor van Berkel, MD, PhD

William M. DeCampli, MD, PhD

A randomized, controlled study of amiodarone for prevention of atrial fibrillation after transthoracic esophagectomy James E. Tisdale, PharmD, Heather.

Multilevel data analysis: What? Why? How?

New treatment approaches create new disease processes: A short guide on how to reduce unexpected events to a minimum Martin Czerny, MD, MBA The Journal.

The lord of the rings Antonio Miceli, MD, PhD

STAT3, Cten, and lung cancer: Simultaneous excitement and caution

The variability of the mitral valve anatomy and terminology

Yang Zhang, MD, Haiquan Chen, MD, PhD

Support Your Specialty

Innovation and science: The future of valve design

Comparative glycomic profiling in esophageal adenocarcinoma

The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery Vinay Badhwar, MD The Journal of Thoracic and.

It's not “just a shunt” but sometimes it should be…

Military surgeons just want to have fun

Do we need a bibliometrician to know which way the wind is blowing?

A first start for lung transplantation?

Confusion still exists regarding postoperative delirium and its etiology after esophagectomy Robert B. Cameron, MD The Journal of Thoracic and Cardiovascular.

Stephen R. Broderick, MD, MPHS

Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD

Michael Lanuti, MD The Journal of Thoracic and Cardiovascular Surgery

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

Novel insights into lung regenerative medicine

Replicating the success of mitral valve repair in the aortic valve

Attachment disorder in thoracoabdominal surgery

The Ross procedure: Time to reevaluate the guidelines

Manuel J. Antunes, MD, PhD, DSc

Video-assisted resection for lung cancer results in fewer complications Lunxu Liu, PhD, MD, FRCS The Journal of Thoracic and Cardiovascular Surgery

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Prognosis and “granularity”: Building on staging foundations?

Metabolomics study of esophageal adenocarcinoma

The origins of open heart surgery at the University of Minnesota 1951 to 1956 Richard A. DeWall, MD The Journal of Thoracic and Cardiovascular Surgery

Bryan M. Burt, MD The Journal of Thoracic and Cardiovascular Surgery

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

The future of cardiac surgery training: A survival guide

Apparently, size matters…in congenital heart disease and brain injury

Ventricular assistant in restrictive cardiomyopathy: Making the right connection Robert D.B. Jaquiss, MD The Journal of Thoracic and Cardiovascular Surgery

Robert J. Cerfolio, MD, FACS, FCCP, Ayesha S. Bryant, MSPH, MD

The continuing challenge of congenital heart disease in China

Should it stay or should it go?

“The more things change…”: The challenges ahead

Kiran H. Lagisetty, David G. Beer, Andrew C. Chang

Managing conflicts of interest

First in line for robotic surgery: Would you want to know?

Aritoshi Hattori, MD, Kenji Suzuki, MD

Lung cancer randomized controlled trials should compare stereotactic body radiation therapy with observation, NOT surgery Raja M. Flores, MD The Journal.

Preoperative PFTs: The answer is blowing in the wind

The evolution of cardiothoracic critical care

Who should decide margin length in pulmonary excision of lung cancer?

Did you like Terminator 3 better than Terminator 2

Samuel Kim, MD The Journal of Thoracic and Cardiovascular Surgery

Journal changes and initiatives

Proceed with caution: The importance of surveillance in patients with pathologic complete response after chemoradiation therapy plus surgery for esophageal.

Deciding how much to pay for effective care

Presentation transcript:

A novel biomarker for the detection of esophageal adenocarcinoma Zane T. Hammoud, MD, Sunil Badve, MD, Romil Saxena, MD, Kenneth A. Kesler, MD, Karen Rieger, MD, Linda H. Malkas, PhD, Robert J. Hickey, PhD The Journal of Thoracic and Cardiovascular Surgery Volume 133, Issue 1, Pages 82-87 (January 2007) DOI: 10.1016/j.jtcvs.2006.09.011 Copyright © 2007 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Negative staining for cancer-specific proliferating cell nuclear antigen in 2 separate high-grade dysplasia specimens. The Journal of Thoracic and Cardiovascular Surgery 2007 133, 82-87DOI: (10.1016/j.jtcvs.2006.09.011) Copyright © 2007 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Positive staining for cancer-specific proliferating cell nuclear antigen in 2 separate specimens of invasive esophageal adenocarcinoma. The Journal of Thoracic and Cardiovascular Surgery 2007 133, 82-87DOI: (10.1016/j.jtcvs.2006.09.011) Copyright © 2007 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 Positive staining for proliferating cell nuclear antigen (A) and negative staining for cancer-specific proliferating cell nuclear antigen (B) in normal esophageal squamous mucosa. The Journal of Thoracic and Cardiovascular Surgery 2007 133, 82-87DOI: (10.1016/j.jtcvs.2006.09.011) Copyright © 2007 The American Association for Thoracic Surgery Terms and Conditions